Quantum量子訊息有限公司

Plasma Fractionation Market

完整報告名稱與涵蓋範圍
Plasma Fractionation Market Size, Share & Trends Analysis Report By Product (Immune-Globulins, Coagulation Factor Concentrates, Albumin, Protease Inhibitors, Other Plasma Products), By Application, By End-User, By Region, And By Segment Forecasts, 2024-2031

報告摘要

In 2023, the Plasma Fractionation Market worldwide was assessed at USD 4.2 Bn. Analysts project it will progress to USD 8.9 Bn by 2031, at a CAGR of 10.1% spanning 2024 to 2031. Plasma Fractionation covers key industry insights & findings from the report: The demand for plasma-derived therapies has been mounting due to the rising prevalence of immune deficiencies, respiratory infections, including ot. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space. Market momentum is underpinned by mounting call for advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies. From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities. From a regional perspective, mature markets in North America and Europe continue to hold marked shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and mounting investment in the sector. Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players. The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.

授權報價

Single User PDF$4,500 USD
Global Site License PDF$9,500 USD

目錄 Table of Contents

Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Plasma Fractionation Market Snapshot Chapter 4. Global Plasma Fractionation Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis – Porter's Five Forces Analysis 4.7. Competitive Landscape & Market Share Analysis 4.8. Impact of Covid-19 Analysis Chapter 5. Market Segmentation 1: By Application Estimates & Trend Analysis 5.1. By Application, & Market Share, 2019 & 2031 5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Application: 5.2.1. Neurology 5.2.2. Immunology 5.2.3. Hematology 5.2.4. Critical Care 5.2.5. Pulmonology 5.2.6. Hemato-Oncology 5.2.7. Rheumatology 5.2.8. Others Chapter 6. Market Segmentation 2: By Product Estimates & Trend Analysis 6.1. By Product & Market Share, 2019 & 2031 6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Product: 6.2.1. Immune-Globulins 6.2.1.1. Intravenous Immune-Globulins 6.2.1.2. Subcutaneous Immune-Globulins 6.2.1.3. Other Immune-Globulins 6.2.2. Coagulation Factor Concentrates 6.2.2.1. Factor VIII 6.2.2.2. Factor IX 6.2.2.3. Von Willebrand Factor 6.2.2.4. Prothrombin Complex Concentrate 6.2.2.5. Fibrinogen Concentrates 6.2.2.6. Factor XIII 6.2.2.7. Others 6.2.3. Albumin 6.2.4. Protease Inhibitors 6.2.5. Other Plasma Products Chapter 7. Market Segmentation 3: By Distribution Channel Estimates & Trend Analysis 7.1. By Distribution Channel & Market Share, 2019 & 2031 7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Distribution Channel: 7.2.1. Hospitals & Clinics 7.2.2. Clinical Research Laboratories 7.2.3. Academic Institutes Chapter 8. Plasma Fractionation Market Segmentation 4: Regional Estimates & Trend Analysis 8.1. North America 8.1.1. North America Plasma Fractionation Market revenue (US$ Million) estimates and forecasts By Application, 2019-2031 8.1.2. North America Plasma Fractionation Market revenue (US$ Million) estimates and forecasts By Product, 2019-2031 8.1.3. North America Plasma Fractionation Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2019-2031 8.1.4. North America Plasma Fractionation Market revenue (US$ Million) estimates and forecasts by country, 2019-2031 8.2. Europe 8.2.1. Europe Plasma Fractionation Market revenue (US$ Million) By Application, 2019-2031 8.2.2. Europe Plasma Fractionation Market revenue (US$ Million) By Product, 2019-2031 8.2.3. Europe Plasma Fractionation Market revenue (US$ Million) By Distribution Channel, 2019-2031 8.2.4. Europe Plasma Fractionation Market revenue (US$ Million) by country, 2019-2031 8.3. Asia Pacific 8.3.1. Asia Pacific Plasma Fractionation Market revenue (US$ Million) By Application, 2019-2031 8.3.2. Asia Pacific Plasma Fractionation Market revenue (US$ Million) By Product, 2019-2031 8.3.3. Asia Pacific Plasma Fractionation Market revenue (US$ Million) By Distribution Channel, 2019-2031 8.3.4. Asia Pacific Plasma Fractionation Market revenue (US$ Million) by country, 2019-2031 8.4. Latin America 8.4.1. Latin America Plasma Fractionation Market revenue (US$ Million) By Application, (US$ Million) 2019-2031 8.4.2. Latin America Plasma Fractionation Market revenue (US$ Million) By Product, (US$ Million) 2019-2031 8.4.3. Latin America Plasma Fractionation Market revenue (US$ Million) By Distribution Channel, (US$ Million) 2019-2031 8.4.4. Latin America Plasma Fractionation Market revenue (US$ Million) by country, 2019-2031 8.5. Middle East & Africa 8.5.1. Middle East & Africa Plasma Fractionation Market revenue (US$ Million) By Application, (US$ Million) 2019-2031 8.5.2. Middle East & Africa Plasma Fractionation Market revenue (US$ Million) By Product, (US$ Million) 2019-2031 8.5.3. Middle East & Africa Plasma Fractionation Market revenue (US$ Million) By Distribution Channel, (US$ Million) 2019-2031 8.5.4. Middle East & Africa Plasma Fractionation Market revenue (US$ Million) by country, 2019-2031

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們